Reneo Pharmaceuticals Inc (RPHM)
1.72
+0.06
(+3.61%)
USD |
NASDAQ |
May 17, 16:00
1.70
-0.02
(-1.16%)
After-Hours: 20:00
Reneo Pharmaceuticals Cash from Investing (Quarterly): 13.76M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 13.76M |
| December 31, 2023 | 39.78M |
| September 30, 2023 | 21.25M |
| June 30, 2023 | -69.01M |
| March 31, 2023 | 18.51M |
| December 31, 2022 | -26.92M |
| September 30, 2022 | -45.44M |
| June 30, 2022 | 9.083M |
| March 31, 2022 | 5.427M |
| Date | Value |
|---|---|
| December 31, 2021 | 8.153M |
| September 30, 2021 | -4.509M |
| June 30, 2021 | -27.00M |
| March 31, 2021 | -0.025M |
| December 31, 2020 | -0.016M |
| September 30, 2020 | 1.193M |
| June 30, 2020 | 1.00M |
| March 31, 2020 | 5.199M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-69.01M
Minimum
Jun 2023
39.78M
Maximum
Dec 2023
-2.916M
Average
1.193M
Median
Sep 2020
Cash from Investing (Quarterly) Benchmarks
| Mirum Pharmaceuticals Inc | -0.013M |
| NovaBay Pharmaceuticals Inc | 1.068M |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.00 |
| Theriva Biologics Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -21.01M |
| Free Cash Flow | -75.65M |
| Free Cash Flow Per Share (Quarterly) | -0.6288 |
| Free Cash Flow Yield | -132.0% |